DRC Medicine Ltd.

S-4 filed

40,803,846 shares

DRC Medicine Ltd. is undergoing a business combination with Ribbon Acquisition Corp, a SPAC, involving a share exchange, domestication of Ribbon to Delaware, and a merger. The transaction includes reclassifying shares, compensating the sponsor, and transitioning to a Delaware corporation. The filing outlines the process for shareholder approval and potential listing on Nasdaq.

DRS/A amended

DRC Medicine Ltd. is proceeding with a business combination involving Ribbon Acquisition Corp, including a share exchange, domestication, and merger. The filing details the redemption of public shares following an extension of the business combination deadline, updated ownership percentages, and compensation for the sponsor. The transaction remains subject to shareholder approval and regulatory conditions.

DRS/A amended

DRC Medicine Ltd. is undergoing a business combination with Ribbon Acquisition Corp via a share exchange, domestication, and merger. The transaction involves converting DRC shareholders' shares into Pubco common stock, relocating Ribbon's incorporation to Delaware, and merging with Merger Sub. The filing outlines compensation for the Sponsor, ownership percentages, and details about the Nasdaq listing of Pubco's shares.

DRS/A amended

DRC Medicine Ltd. is undergoing a business combination with Ribbon Acquisition Corp, involving a share exchange, domestication of Ribbon as a Delaware corporation, and a merger. The transaction includes compensation for the sponsor, details on ownership percentages, and plans for Pubco's Nasdaq listing. The filing outlines the process for shareholder approval and potential risks associated with the merger.

DRS/A amended

DRC Medicine Ltd. is undergoing a business combination with Ribbon Acquisition Corp, involving a share exchange, domestication of Ribbon as a Delaware corporation, and a merger. The filing outlines the reclassification of shares, redemption rights for public shareholders, and the transition to Pubco Common Stock. The process requires shareholder approval and is subject to regulatory and market conditions.

DRS filed

DRC Medicine Ltd. is undergoing a business combination with Ribbon Acquisition Corp, a SPAC, involving a share exchange, domestication, and merger. The transaction includes a share exchange between DRC and Pubco, domestication of Ribbon as a Delaware corporation, and a merger of Ribbon with Merger Sub. The deal aims to list DRC's shares on Nasdaq under the symbol [ ]. The filing includes details on shareholder approvals, redemption rights, and a fairness opinion from an appraisal firm.